CoChat

Modulatory effects of perforin gene dosage on pathogen-associated blood-brain barrier (BBB) disruption

Willenbring, Robin C., Jin, Fang, Hinton, David J., Hansen, Mike, Choi, Doo-Sup, Pavelko, Kevin D., Johnson, Aaron J. · 2016 · Journal of Neuroinflammation
Cited by 26

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12974-016-0673-9

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 45

  1. Huber JD, Egleton RD, Davis TP. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 2001;24:719–25. · DOI · Paper page
  2. Brown H, Hien TT, Day N, Mai NT, Chuong LV, et al. Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol. 1999;25:331–40. · DOI · Paper page
  3. Lacerda-Queiroz N, Rodrigues DH, Vilela MC, Rachid MA, Soriani FM, et al. Platelet-activating factor receptor is essential for the development of experimental cerebral malaria. Am J Pathol. 2012;180:246–55. · DOI
  4. Marchi N, Johnson AJ, Puvenna V, Johnson HL, Tierney W, et al. Modulation of peripheral cytotoxic cells and ictogenesis in a model of seizures. Epilepsia. 2011;52:1627–34. · DOI
  5. Marchi N, Granata T, Ghosh C, Janigro D. Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches. Epilepsia. 2012;53:1877–86. · DOI · Paper page
  6. Medana IM, Turner GD. Human cerebral malaria and the blood-brain barrier. Int J Parasitol. 2006;36:555–68. · DOI · Paper page
  7. Minagar A, Alexander JS. Blood-brain barrier disruption in multiple sclerosis. Mult Scler. 2003;9:540–9. · DOI · Paper page
  8. Pirko I, Suidan GL, Rodriguez M, Johnson AJ. Acute hemorrhagic demyelination in a murine model of multiple sclerosis. J Neuroinflammation. 2008;5:31. · DOI
  9. Schneider SW, Ludwig T, Tatenhorst L, Braune S, Oberleithner H, et al. Glioblastoma cells release factors that disrupt blood-brain barrier features. Acta Neuropathol. 2004;107:272–6. · DOI · Paper page
  10. Talavera D, Castillo AM, Dominguez MC, Gutierrez AE, Meza I. IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol. 2004;85:1801–13. · DOI · Paper page
  11. An J, Zhou DS, Zhang JL, Morida H, Wang JL, et al. Dengue-specific CD8+ T cells have both protective and pathogenic roles in dengue virus infection. Immunol Lett. 2004;95:167–74. · doi:10.1016/j.imlet.2004.07.006
  12. Kilpatrick ED, Terajima M, Koster FT, Catalina MD, Cruz J, et al. Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J Immunol. 2004;172:3297–304. · DOI · Paper page
  13. Suidan GL, Dickerson JW, Chen Y, McDole JR, Tripathi P, et al. CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions. J Immunol. 2010;184:1031–40. · DOI · Paper page
  14. Suidan GL, McDole JR, Chen Y, Pirko I, Johnson AJ. Induction of blood brain barrier tight junction protein alterations by CD8 T cells. PLoS One. 2008;3:e3037. · DOI · Paper page
  15. Johnson HL, Willenbring RC, Jin F, Manhart WA, LaFrance SJ, et al. Perforin competent CD8 T cells are sufficient to cause immune-mediated blood-brain barrier disruption. PLoS One. 2014;9:e111401. · DOI · Paper page
  16. Johnson HL, Chen Y, Jin F, Hanson LM, Gamez JD, et al. CD8 T cell-initiated blood-brain barrier disruption is independent of neutrophil support. J Immunol. 2012;189:1937–45. · DOI
  17. Voskoboinik I, Thia MC, Trapani JA. A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis. Blood. 2005;105:4700–6. · DOI
  18. An O, Gursoy A, Gurgey A, Keskin O. Structural and functional analysis of perforin mutations in association with clinical data of familial hemophagocytic lymphohistiocytosis type 2 (FHL2) patients. Protein Sci. 2013;22:823–39. · DOI
  19. Goransdotter Ericson K, Fadeel B, Nilsson-Ardnor S, Soderhall C, Samuelsson A, et al. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet. 2001;68:590–7. · DOI · Paper page
  20. Mhatre S, Madkaikar M, Desai M, Ghosh K. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis (FHL) patients in India. Blood Cells Mol Dis. 2015;54:250–7. · DOI
  21. Muralitharan S, Wali YA, Dennison D, Lamki ZA, Zachariah M, et al. Novel spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis in ethnic Omani patients. Am J Hematol. 2007;82:1099–102. · DOI
  22. Voskoboinik I, Thia MC, De Bono A, Browne K, Cretney E, et al. The functional basis for hemophagocytic lymphohistiocytosis in a patient with co-inherited missense mutations in the perforin (PFN1) gene. J Exp Med. 2004;200:811–6. · DOI
  23. Zhang K, Johnson JA, Biroschak J, Villanueva J, Lee SM, et al. Familial haemophagocytic lymphohistiocytosis in patients who are heterozygous for the A91V perforin variation is often associated with other genetic defects. Int J Immunogenet. 2007;34:231–3. · DOI
  24. Zur Stadt U, Beutel K, Weber B, Kabisch H, Schneppenheim R, et al. A91V is a polymorphism in the perforin gene not causative of an FHLH phenotype. Blood. 2004;104:1909. author reply 1910. · DOI · Paper page
  25. House IG, Thia K, Brennan AJ, Tothill R, Dobrovic A, et al. Heterozygosity for the common perforin mutation, p.A91V, impairs the cytotoxicity of primary natural killer cells from healthy individuals. Immunol Cell Biol. 2015;93:575–80. · DOI · Paper page
  26. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286:1957–9. · DOI · Paper page
  27. Voskoboinik I, Dunstone MA, Baran K, Whisstock JC, Trapani JA. Perforin: structure, function, and role in human immunopathology. Immunol Rev. 2010;235:35–54. · DOI · Paper page
  28. Trapani JA, Thia KY, Andrews M, Davis ID, Gedye C, et al. Human perforin mutations and susceptibility to multiple primary cancers. Oncoimmunology. 2013;2:e24185. · DOI
  29. Revelo XS, Tsai S, Lei H, Luck H, Ghazarian M, et al. Perforin is a novel immune regulator of obesity related insulin resistance. Diabetes. 2015;64(1):90–103. · DOI · Paper page
  30. Orilieri E, Cappellano G, Clementi R, Cometa A, Ferretti M, et al. Variations of the perforin gene in patients with type 1 diabetes. Diabetes. 2008;57:1078–83. · DOI
  31. Prugnolle F, Manica A, Charpentier M, Guegan JF, Guernier V, et al. Pathogen-driven selection and worldwide HLA class I diversity. Curr Biol. 2005;15:1022–7. · DOI · Paper page
  32. Brennan AJ, House IG, Oliaro J, Ramsbottom KM, Hagn M, et al. A method for detecting intracellular perforin in mouse lymphocytes. J Immunol. 2014;193:5744–50. · DOI
  33. Gebhard JR, Perry CM, Harkins S, Lane T, Mena I, et al. Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. Am J Pathol. 1998;153:417–28. · DOI · Paper page
  34. Pavelko KD, Girtman MA, Mitsunaga Y, Mendez-Fernandez YV, Bell MP, et al. Theiler’s murine encephalomyelitis virus as a vaccine candidate for immunotherapy. PLoS One. 2011;6:e20217. · DOI
  35. Johnson AJ, Mendez-Fernandez Y, Moyer AM, Sloma CR, Pirko I, et al. Antigen-specific CD8+ T cells mediate a peptide-induced fatal syndrome. J Immunol. 2005;174:6854–62. · DOI · Paper page
  36. Pirko I, Nolan TK, Holland SK, Johnson AJ. Multiple sclerosis: pathogenesis and MR imaging features of T1 hypointensities in a [corrected] murine model. Radiology. 2008;246:790–5. · DOI
  37. Denic A, Macura SI, Mishra P, Gamez JD, Rodriguez M, et al. MRI in rodent models of brain disorders. Neurotherapeutics. 2011;8:3–18. · DOI
  38. Pirko I, Gamez J, Johnson AJ, Macura SI, Rodriguez M. Dynamics of MRI lesion development in an animal model of viral-induced acute progressive CNS demyelination. Neuroimage. 2004;21:576–82. · DOI
  39. Pirko I, Johnson AJ, Chen Y, Lindquist DM, Lohrey AK, et al. Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis. Neuroimage. 2011;54:802–6. · DOI
  40. Vadnie CA, Hinton DJ, Choi S, Choi Y, Ruby CL, et al. Activation of neurotensin receptor type 1 attenuates locomotor activity. Neuropharmacology. 2014;85:482–92. · DOI
  41. Johnson AJ, Njenga MK, Hansen MJ, Kuhns ST, Chen LP, et al. Prevalent class I-restricted T-cell response to the Thelier’s virus epitope D-b : VP2(121-130) in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J Virol. 1999;73:3702–8. · DOI · Paper page
  42. Brennan AJ, Chia J, Trapani JA, Voskoboinik I. Perforin deficiency and susceptibility to cancer. Cell Death Differ. 2010;17:607–15. · DOI
  43. Urrea Moreno R, Gil J, Rodriguez-Sainz C, Cela E, LaFay V, et al. Functional assessment of perforin C2 domain mutations illustrates the critical role for calcium-dependent lipid binding in perforin cytotoxic function. Blood. 2009;113:338–46. · DOI
  44. Terrell CE, Jordan MB. Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells. Blood. 2013;121:5184–91. · DOI · Paper page
  45. Terrell CE, Jordan MB. Mixed hematopoietic or T-cell chimerism above a minimal threshold restores perforin-dependent immune regulation in perforin-deficient mice. Blood. 2013;122:2618–21. · DOI

Cited by

See all 26

Metadata

Authors
Willenbring, R. C., Jin, F., Hinton, D. J., Hansen, M., Choi, D.-S., Pavelko, K. D., & Johnson, A. J.
Venue
Journal of Neuroinflammation
Published
2016-08-31
Volume
13
Issue
1
ISSN
1742-2094
Cited by
26
References
3
Language
en
Licence
Funders
  • National Institutes of Health (RO1 NS060881)
  • National Institute of Neurological Disorders and Stroke (R56 NS94150)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modulatory effects of perforin gene dosage on pathogen-associated blood-brain barrier (BBB) disruption. https://app.cochat.ai/papers/10.1186/s12974-016-0673-9
The paper
Willenbring, R. C., Jin, F., Hinton, D. J., Hansen, M., Choi, D.-S., Pavelko, K. D., & Johnson, A. J. (2016). Modulatory effects of perforin gene dosage on pathogen-associated blood-brain barrier (BBB) disruption. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-016-0673-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.